Rentokil Initial announced it has acquired Vector Disease Acquisition (VDA), a provider of mosquito control services based in Little Rock, Ark.
VDA provides vector control services, including weekly monitoring of mosquito levels, species identification and disease testing (using its in-house laboratory) and control of both adult and larval mosquitoes from the ground and using aircraft. VDA also provides lake management services, a new route-based service line for Rentokil North America.
VDA operates from 52 offices in 32 U.S. states with annual revenues for the 12 months prior to acquisition at approximately $47 million, making this Rentoki’s largest U.S. acquisition since it acquired Steritech in 2105. VDA has more than 160 full-time and 350 seasonal employees. In line with this acquisition, Rentokil announced in a press release it is establishing a new global center of excellence for mosquito control, which will be based in North America.
VDA also provides lake management services, a new route-based service line for Rentokil North America. Invasive aquatic plants destroy fish and wildlife, and clog pipes used for drinking water, hydroelectric and irrigation supplies. Services include chemical treatments, mechanical vegetation removal, aeration and fountain management. The Lake Management division, which is predominately a contract portfolio business, is also the largest of its type in North America.
Commenting on the acquisition, Andy Ransom, CEO of Rentokil Initial, said:
"The growing threat to public health from mosquitoes makes vector control an important and growing part of the overall pest control market. Factors such as climate change and increased travel are leading to more vector-borne disease outbreaks than ever before.
"We are now positioned strongly in two attractive markets that are characterized by good growth, high technical skill level and strong regulatory requirements, attributes that play well to Rentokil Initial's traditional strengths and expertise. This is another important step towards our ambition to create a business in North America with revenues of c. $1.5bn and margins of c. 18% by the end of 2020. Given the increasing demand for mosquito control in many parts of the world and the unrivalled expertise in VDA, this is also a significant acquisition for our global pest control business."
Paul Giannamore of The Potomac Company represented and acted as exclusive financial advisor to Vector Disease Acquisition, LLC.
--with additional reporting from Brad Harbsion